Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

‘Advanced access’ scheduling pleases patients, strengthens PCPs
Primary care providers can significantly improve practice performance as well as patient satisfaction by making one workaday adjustment: leaving some appointment slots open to accommodate walk-ins throughout the day.
FDA confirms Class I recall for vascular device used by cardiologists and surgeons
The issue at the heart of this recall has been linked to three patient deaths.
Nationwide private-equity backed hospital chain announces shift to nonprofit business model
Quorum Health said the move will allow it to save money through tax exemptions and provide its 11 hospitals with access to the 340B Drug Pricing Program. The health system is majority-owned by Goldentree Asset Management.
BATMAN to the rescue: TMVR technique helps cardiologists reduce risk of LVOT obstruction
LVOT obstruction is a serious complication of TMVR. BATMAN may help protect patients from LVOT obstruction without leading to any additional risks.
How TAVR valve implant depth impacts clinical outcomes
TAVR procedures with a higher implant depth are associated with certain clinical benefits after one year, according to a new study of data from more than 600 patients.

ICU diary-keeping: There’s an AI for that

Intensive care units around the world use daily diaries to track patients’ emotional as well as physical ups and downs. Many find that keeping these helpful resources can add to nurses’ already-heavy workloads. How might generative AI help?

Industry Watcher’s Digest

IT departments are budgeting more for AI in 2025 than for any other single area of investment.

artificial intelligence AI in healthcare

Stanford HAI lookback: Best-read blog posts of 2024

The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.

IV hospital room intravenous drip solution

Industry Watcher’s Digest

The FDA has finalized its recommendations for getting AI-equipped medical devices approved.

Providers, payers share actionable experiences involving healthcare AI

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).

Q&A: Pioneer heart surgeon on the development and long-term potential of robotic aortic valve replacement

It's early for RAVR, but the minimally invasive technique has already started gaining momentum as an alternative to both SAVR and TAVR. We spoke to Vinay Badhwar, MD, one of the world’s leading voices in robotic heart surgery, to learn more.

Heart surgeons with the WVU Heart and Vascular Institute have made a bit of history, performing the world’s first combined robotic aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) procedure—all through one small incision. Patients requiring these procedures typically undergo open-heart surgery.

Heart surgeons perform world’s first combined robotic AVR and CABG

The entire robotic procedure was performed through one small incision. Surgeons originally recommended the 73-year-old patient undergo open-heart surgery, but she requested a less invasive alternative.

Off-label TAVR for native aortic regurgitation linked to worse outcomes

Targeting aortic regurgitation with TAVR valves built to treat aortic stenosis may be the only option a cardiologist has—but valves designed specifically to treat AR are linked to much better outcomes, according to a new meta-analysis. Edwards Lifesciences recently acquired the two companies at the center of this study, JenaValve and JC Medical.

Care Delivery

‘Advanced access’ scheduling pleases patients, strengthens PCPs

FDA confirms Class I recall for vascular device used by cardiologists and surgeons

Nationwide private-equity backed hospital chain announces shift to nonprofit business model

BATMAN to the rescue: TMVR technique helps cardiologists reduce risk of LVOT obstruction

How TAVR valve implant depth impacts clinical outcomes